Population Pharmacokinetics of Lopinavir in Severely Malnourished HIV-infected Children and the Effect on Treatment Outcomes

被引:9
|
作者
Archary, Moherndran [1 ,2 ]
Mcllleron, Helen [3 ]
Bobat, Raziya [2 ]
La Russa, Phillip [4 ]
Sibaya, Thobekile [2 ]
Wiesner, Lubbe [3 ]
Hennig, Stefanie [5 ]
机构
[1] Univ KwaZulu Natal, King Edward VIII Hosp, Dept Paediat & Children Hlth, Durban, South Africa
[2] Univ KwaZulu Natal, Dept Paediat & Children Hlth, Durban, South Africa
[3] Univ Cape Town, Dept Med, Div Clin Pharmacol, Cape Town, South Africa
[4] Columbia Univ, Coll Phys & Surg, Dept Paediat, New York, NY USA
[5] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia
基金
新加坡国家研究基金会; 美国国家卫生研究院;
关键词
lopinavir; population pharmacokinetics; severe acute malnutrition; HIV; children; ANTIRETROVIRAL THERAPY; ANTITUBERCULAR TREATMENT; LOPINAVIR/RITONAVIR; COMBINATION; NEVIRAPINE; MALNUTRITION; RITONAVIR; TABLETS; RIFAMPICIN; FAILURE;
D O I
10.1097/INF.0000000000001867
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: In developing countries, malnutrition remains a common clinical syndrome at antiretroviral treatment (ART) initiation. Physiologic changes because of malnutrition and during nutritional recovery could affect the pharmacokinetics of antiretroviral drugs. Methods: HIV-infected children admitted with severe acute malnutrition were randomized to early or delayed initiation of lopinavir (LPV)/ritonavir, abacavir and lamivudine using World Health Organization weight band dosage charts. LPV concentrations were measured on day 1 and day 14. Thereafter, patients were followed-up to week 48. The population pharmacokinetics of LPV was described using NONMEM v7.3. Covariates were screened to assess their influence on the pharmacokinetics of LPV, and the relationship between pharmacokinetic variability and treatment outcomes were assessed. Results: Five hundred and two LPV concentrations were collected from 62 pediatric patients 0.1-3.9 years of age (median: 0.9 years). Rifampin-based antituberculosis treatment and "super-boosted" LPV/ritonavir were prescribed in 20 patients. LPV disposition was well described by a one-compartment model with first-order elimination. Neither randomization to early or delayed ART, tuberculosis comedications nor anthropometrical measurements explained the pharmcokinetic variability. Allometrically scaled fat-free mass influenced apparent clearance (CL/F) and volume of distribution (V-d/F). Pharmacokinetic exposure did not correlate with virologic outcomes or death at 12 or 48 weeks. Conclusions: LPV pharmacokinetics was influenced by fat-free mass and not by timing of ART initiation or tuberculosis comedication in severely malnourished HIV-infected children. LPV pharmacokinetics was found to be highly variable and bioavailability greatly reduced, resulting in a high CL estimate in this population. The role of LPV dose adjustment should be further evaluated in severely malnourished children initiating ART.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 50 条
  • [1] Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis
    Ren, Yuan
    Nuttall, James J. C.
    Egbers, Claire
    Eley, Brian S.
    Meyers, Tammy M.
    Smith, Peter J.
    Maartens, Gary
    McIlleron, Helen M.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (05) : 566 - 569
  • [2] Lopinavir population pharmacokinetics on HIV-infected pregnant women
    Bouillon-Pichault, M.
    Treluyer, J. M.
    Rey, E.
    Pons, G.
    Jullien, V.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 23 - 23
  • [3] Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia
    Boettiger, David C.
    Aurpibul, Linda
    Hudaya, Dina Mukiarti
    Fong, Siew M.
    Lumbiganon, Pagakrong
    Saphonn, Vonthanak
    Truong, Khanh H.
    Hansudewechakul, Rawiwan
    Nguyen, Lam V.
    Do, Viet C.
    Bunupuradah, Torsak
    Chokephaibulkit, Kulkanya
    Yusoff, Nik Khairulddin Nik
    Kumarasamy, Nagalingeswaran
    Wati, Dewi Kumara
    Razali, Kamarul Azahar
    Kariminia, Azar
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (05) : e144 - e151
  • [4] Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children
    Zhang, Chao
    McIlleron, Helen
    Ren, Yuan
    van der Walt, Jan-Stefan
    Karlsson, Mats O.
    Simonsson, Ulrika S. H.
    Denti, Paolo
    [J]. ANTIVIRAL THERAPY, 2012, 17 (01) : 25 - 33
  • [5] Population Pharmacokinetics of Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients
    Lopez Aspiroz, Elena
    Santos Buelga, Dolores
    Cabrera Figueroa, Salvador
    Lopez Galera, Rosa Maria
    Ribera Pascuet, Esteban
    Dominguez-Gil Hurle, Alfonso
    Garcia Sanchez, Maria Jose
    [J]. THERAPEUTIC DRUG MONITORING, 2011, 33 (05) : 573 - 582
  • [6] Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children
    Doaa Elsherbiny
    Yuan Ren
    Helen McIlleron
    Gary Maartens
    Ulrika S. H. Simonsson
    [J]. European Journal of Clinical Pharmacology, 2010, 66 : 1017 - 1023
  • [7] Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children
    Elsherbiny, Doaa
    Ren, Yuan
    McIlleron, Helen
    Maartens, Gary
    Simonsson, Ulrika S. H.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (10) : 1017 - 1023
  • [8] Population pharmacokinetics of abacavir and lamivudine in severely malnourished human immunodeficiency virus-infected children in relation to treatment outcomes
    Archary, Moherndran
    McIlleron, Helen
    Bobat, Raziya
    LaRussa, Philip
    Sibaya, Thobekile
    Wiesner, Lubbe
    Hennig, Stefanie
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (09) : 2066 - 2075
  • [9] Population Pharmacokinetics of Dapsone in HIV-Infected Children
    Mark Mirochnick
    Ellen Cooper
    Jing Xu
    Jane Lindsey
    Edmund Capparelli
    Ken McIntosh
    James McNamara
    Lynne M Mofenson
    David Jacobus
    [J]. Pediatric Research, 1999, 45 (7) : 168 - 168
  • [10] Population pharmacokinetics of dapsone in HIV-infected children
    Mirochnick, M
    Cooper, E
    Xu, J
    Lindsey, J
    Capparelli, E
    McIntosh, K
    McNamara, J
    Mofenson, LM
    Jacobus, D
    [J]. PEDIATRIC RESEARCH, 1999, 45 (04) : 168A - 168A